|
Volumn 45, Issue 9, 2002, Pages 1825-1834
|
Rational design, synthesis, and biological activity of novel conformationally restricted vitamin D analogues, (22R)- and (22S)-22-ethyl-1,25-dihydroxy-23,24-didehydro-24a,24b-dihomo-20-epivitamin D3
|
Author keywords
[No Author keywords available]
|
Indexed keywords
22 ETHYL 1,25 DIHYDROXY 23,24 DIDEHYDRO 24A,24B DIHOMO 20 EPIVITAMIN D3;
UNCLASSIFIED DRUG;
VITAMIN D DERIVATIVE;
ARTICLE;
CELL DIFFERENTIATION;
DRUG CONFORMATION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ISOMERISM;
LIGAND BINDING;
MOLECULAR MODEL;
RECEPTOR AFFINITY;
SITE DIRECTED MUTAGENESIS;
STEREOCHEMISTRY;
ANIMALS;
CALCIUM;
CELL DIFFERENTIATION;
COS CELLS;
CRYSTALLOGRAPHY, X-RAY;
HL-60 CELLS;
HUMANS;
LIGANDS;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
MUTAGENESIS, SITE-DIRECTED;
RATS;
RECEPTORS, CALCITRIOL;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
TRANS-ACTIVATION (GENETICS);
TRANSCRIPTION, GENETIC;
VITAMIN D;
VITAMIN D DEFICIENCY;
|
EID: 0037171848
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm0105631 Document Type: Article |
Times cited : (34)
|
References (30)
|